SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001213900-21-004020
Filing Date
2021-01-25
Accepted
2021-01-25 15:51:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 7859
  Complete submission text file 0001213900-21-004020.txt   8712
Mailing Address ALTER POSTPLATZ 2 STANS V8 CH-6370
Business Address ALTER POSTPLATZ 2 STANS V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations